Quantcast
 
New book by Larry Connors Click here Improve your trading - See how


OPXA

OPXA: To Present At Rodman & Renshaw Investment Conference @ 17:45 ET [delayed] - 11/11 - 04:23 PM ET

Opexa to Present at the Rodman & Renshaw 10th Annual Healthcare Conference - 11/04 - 07:30 AM ET

Opexa reports additional positive data from Phase IIb multiple sclerosis study - 10/24 - 09:10 AM ET

OPXA: Conference call regarding Additional Data from the TERMS Study and Third Quarter Results @ 08:30 ET Today [delayed] - 10/23 - 08:25 AM ET

BRIEF-Opexa Therapeutics reports Q3 results - 10/23 - 08:07 AM ET

OPEXA THERAPEUTICS INC REUTERS ESTIMATES Q3 SHR VIEW $-0.31 - 10/23 - 08:05 AM ET

OPEXA THERAPEUTICS INC Q3 SHR LOSS $0.28 - 10/23 - 08:04 AM ET

Opexa Provides Additional Promising Data Including Statistically Significant Reduction in Disability With Tovaxin(R) for the Treatment of Multiple Sclerosis - 10/23 - 07:15 AM ET

Opexa to Host Third Quarter Financial Results and Corporate Update Conference Call on October 23, 2008 - 10/20 - 04:41 PM ET

Opexa reports top-line data from Phase IIb multiple sclerosis study - 09/22 - 01:11 PM ET

Top-Line Data from Opexa's Phase IIb Tovaxin(R) Study to be Presented at World Congress on Treatment and Research in Multiple Sclerosis - 09/11 - 07:30 AM ET

Opexa and MRF collaborate on multiple sclerosis research program - 09/04 - 10:57 AM ET

OPXA: Research Partnership w/Myelin Repair Foundation - 09/03 - 08:27 AM ET

Opexa Therapeutics and Myelin Repair Foundation Partner on Novel Multiple Sclerosis Research Program - 09/03 - 07:30 AM ET

Opexa Therapeutics Reports Second Quarter 2008 Financial Results and Recent Corporate Highlights - 08/14 - 07:30 AM ET

Opexa Therapeutics Inc concludes private placement - 08/14 - 05:04 AM ET

Opexa Therapeutics Completes $3 Million Financing - 08/13 - 07:30 AM ET

Opexa wins positive review for Phase IIb multiple sclerosis study - 07/09 - 06:22 AM ET

OPXA: Data Safety Monitoring Board Recommends Continuation of Ph IIb Study - 07/08 - 08:09 AM ET

Opexa's Phase IIb Study of Tovaxin(R) Receives Positive Review from Data Safety Monitoring Board - 07/08 - 08:00 AM ET

Page 1 of 3     1  2   3      Previous  |  Next

<< Back to Stock Index

 

Most Popular News
PREMIER SPONSORED LINKS
TRADE CENTER
 
The TradingMarkets Directory
RELATED SITES
Nothing but forex
Please call 1-213-955-5858 ext. 1

About TradingMarkets | Contact | Advertise | Careers | Link to Us | Site Map | Help | Terms & Conditions | Privacy Policy | Return Policy | Testimonials | Feedback


All analyst commentary provided on TradingMarkets.com is provided for educational purposes only. The analysts and employees or affiliates of TradingMarkets.com may hold positions in the stocks or industries discussed here. This information is NOT a recommendation or solicitation to buy or sell any securities. Your use of this and all information contained on TradingMarkets.com is governed by the Terms and Conditions of Use. Please click the link to view those terms. Follow this link to read our Editorial Policy.

© 2008 The Connors Group, Inc.